Phase Ib Dose Escalation Study Of Bortezomib And Sunitin

Phase Ib Dose Escalation Study Of Bortezomib And Sunitin

Sponsor(s)

Pfizere

Principal Investigator(s)John Kauh, MD
Dates9/07/2007 - 12/31/2012